Several firms act on the acquisition of H. Hemo and Vita by BTG
Tauil & Chequer, Demarest, Azevedo Sette and Pinheiro Guimarães advised on a transaction involving the acquisition of control of H. Hemo and Vita Participações, two of the largest hemotherapy chains in Brazil, by vehicles of BTG Pactual through an investment in HVB Participações, a company which, after implementation of a corporate reorganization, now holds the direct and indirect control of all operational subsidiaries of H. Hemo and Vita groups.
The transaction value was BRL 560 million.
Tauil & Chequer Advogados in association with Mayer Brown advised BTG Pactual. The team was led by partner Bruno Salzano (pictured left) and senior associate Maurício Veiga, partner Adriana Giannini and associates Luciano Campos, Bruno Ribeiro and José Muricy and Felipe Pereira.
Demarest advised H. Hemo Hemoterapia (Brasil) and relied on led partner Joyl Gondim (pictured center-left); partners Bruno Drago, André Novaski, Carlos Eduardo Orsolon; associates Lucas Lopes Parra, Marcelo Peloso, Marco Antonio Silva Fonseca, Otavio Cividanes, Rodrigo Zilio.
Azevedo Sette advised Vita Participações and relied on led partners Luiz Sette (pictured center-right), and Natália Meirelles (pictured right), partners Luiz Salles and Frederico Fonseca; associates Júlia Alves, Vitória Miranda, and Ana Carolina Veloso, Marco Chung.
